A Study in Healthy Volunteers to Evaluate Serum and Urine Levels of the Investigational Product Versus Comparator.
This study has been completed.
Information provided by:
First received: January 19, 2006
Last updated: March 5, 2008
Last verified: March 2008
The purpose of the study is to obtain initial pharmacokinetic data in healthy patients after dosing a combination of the study medications.
|Study Design:||Allocation: Randomized
Endpoint Classification: Pharmacokinetics Study
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Treatment
Resource links provided by NLM:
Drug Information available for: Formoterol fumarate Formoterol Fluticasone propionate Fluticasone Arformoterol TartrateU.S. FDA Resources
Further study details as provided by Dey:
Contacts and Locations